- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about AXSM
Recent news which mentions AXSM
Here's Why Axsome Therapeutics Stock Is Surging Today
September 01, 2021
Tickers
AXSM
From Motley Fool
10 Biggest Price Target Changes For Monday
August 30, 2021
From Benzinga
Which Biotech Stock Will Shock the Market in 2022?
August 27, 2021
From Motley Fool
12 Health Care Stocks Moving In Tuesday's After-Market Session
August 24, 2021
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
August 23, 2021
From Benzinga
From InvestorPlace
The Week Ahead In Biotech: Cara FDA Decision, Ascendis Earnings, Aileron Data Presentation And More
August 22, 2021
From Benzinga
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
August 20, 2021
From Benzinga
Could Biogen Acquire Axsome Therapeutics?
August 20, 2021
From Motley Fool
From Benzinga
From Benzinga
From Benzinga
2 Beaten-Down Biotech Stocks: Are They Bargains Now?
August 17, 2021
From Motley Fool
The Week Ahead In Biotech (Aug. 15-21): Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow
August 15, 2021
From Benzinga
The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
August 13, 2021
From Benzinga
Is Axsome Therapeutics Stock Ready to Rebound?
August 12, 2021
From Motley Fool
The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
August 11, 2021
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
August 10, 2021
From Benzinga
10 Biggest Price Target Changes For Tuesday
August 10, 2021
From Benzinga
The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts
August 10, 2021
From Benzinga
68 Biggest Movers From Yesterday
August 10, 2021
From Benzinga
Axsome Therapeutics, inc (AXSM) Q2 2021 Earnings Call Transcript
August 09, 2021
Tickers
AXSM
From Motley Fool
Mid-Afternoon Market Update: Aterian Falls After Q2 Results; Select Interior Concepts Shares Spike Higher
August 09, 2021
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
August 09, 2021
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.